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Background: Myocardial disarray is an important histological feature of hypertrophic cardiomyopathy (HCM) which
has been studied post-mortem, but its in-vivo prevalence and extent is unknown. Cardiac Diffusion Tensor Imaging
(cDTI) provides information on mean intravoxel myocyte orientation and potentially myocardial disarray. Recent
technical advances have improved in-vivo cDTI, and the aim of this study was to assess the interstudy
reproducibility of quantitative in-vivo cDTI in patients with HCM.
Methods and results: A stimulated-echo single-shot-EPI sequence with zonal excitation and parallel imaging was
implemented. Ten patients with HCM were each scanned on 2 different days. For each scan 3 short axis
mid-ventricular slices were acquired with cDTI at end systole. Fractional anisotropy (FA), mean diffusivity (MD), and
helix angle (HA) maps were created using a cDTI post-processing platform developed in-house. The mean ± SD
global FA was 0.613 ± 0.044, MD was 0.750 ± 0.154 × 10-3 mm2/s and HA was epicardium −34.3 ± 7.6°,
mesocardium 3.5 ± 6.9° and endocardium 38.9 ± 8.1°. Comparison of initial and repeat studies showed global
interstudy reproducibility for FA (SD = ± 0.045, Coefficient of Variation (CoV) = 7.2%), MD (SD = ± 0.135 × 10-3 mm2/s,
CoV = 18.6%) and HA (epicardium SD = ± 4.8°; mesocardium SD = ± 3.4°; endocardium SD = ± 2.9°). Reproducibility
of FA was superior to MD (p = 0.003). Global MD was significantly higher in the septum than the reference lateral
wall (0.784 ± 0.188 vs 0.750 ± 0.154 x10-3 mm2/s, p < 0.001). Septal HA was significantly lower than the reference
lateral wall in all 3 transmural layers (from −8.3° to −10.4°, all p < 0.001).
Conclusions: To the best of our knowledge, this is the first study to assess the interstudy reproducibility of DTI in
the human HCM heart in-vivo and the largest cDTI study in HCM to date. Our results show good reproducibility of
FA, MD and HA which indicates that current technology yields robust in-vivo measurements that have potential
clinical value. The interpretation of regional differences in the septum requires further investigation.
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Hypertrophic cardiomyopathy (HCM) is the most common
inherited cardiomyopathy and affects 1 in 500 of the
general population [1,2]. The majority of patients experi-
ence a benign clinical course, however, a small but signifi-
cant minority experience major adverse sequelae, including
sudden cardiac death and heart failure mortality [2,3]. His-
tologically, HCM manifests as fibrosis, microvascular ab-
normalities, myocyte hypertrophy and myocyte disarray.
Disarray may play a key role the in the genesis of the sub-
strate responsible for malignant ventricular arrhythmias
and myocardial contractile dysfunction, [4] but to date,
insights into the extent and spatial distribution of myocyte
disarray have been derived largely from small post-mortem
series examining hearts obtained after sudden cardiac death
[5,6,7,8] These studies have considerable selection bias and
as a result, the in-vivo prevalence and functional conse-
quences of disarray in HCM remain unknown. Further-
more, the diagnostic utility of disarray in HCM is unclear
as the phenomenon has also been described in a variety of
congenital and acquired myocardial diseases [9,10]. These
include other conditions associated with left ventricular
hypertrophy, such as aortic stenosis and hypertensive heart
disease, [11] the latter frequently posing a challenge in the
differential diagnosis of HCM [12].
Cardiovascular magnetic resonance (CMR) is assuming
an increasingly important role in the diagnosis and eva-
luation of HCM [13,14]. It allows the accurate assessment
of hypertrophy; [15] the detection and quantification of
fibrosis through late gadolinium enhancement (LGE)
imaging and T1-relaxometry; [16,17] and the identification
of microvascular dysfunction through first-pass perfusion
imaging [18]. The assessment of disarray however has
proved more challenging. The emerging CMR-based tech-
nique of cardiovascular diffusion tensor imaging (cDTI)
may afford this opportunity [19] and could have diagnostic
utility in the differential diagnosis of left ventricular hyper-
trophy. This technology has been successfully applied to
assess nerve fibre architecture in the central nervous sys-
tem. The orientation of nerve tracts is inferred by asses-
sing the diffusivity of water molecules which preferentially
occurs parallel to the nerve fibres [20]. However, the in-
vivo application of such techniques to the myocardial
architecture has been limited by the challenge of resolving
the molecular diffusion of water molecules in the presence
of bulk motion of the heart due to cardiac contraction and
respiratory motion [21,22]. Studies in animal models have
suggested that this technique may give useful insights into
disarray in HCM, [23,24] but to date there is only one pre-
vious in-vivo human pilot study of 5 HCM patients [25].
We previously described the development of a novel pulse
sequence for cDTI which draws on technical improve-
ments and 3 T imaging in normal subjects [22]. In the
current study, we applied this novel technique to quantifythe reproducibility of cDTI in HCM for Fractional Aniso-
tropy (FA), Mean Diffusivity (MD), and Helix Angle (HA)
maps to determine its robustness for potential clinical use.
Methods
Study population
We prospectively enrolled 10 patients with HCM re-
ferred for CMR at Royal Brompton Hospital. HCM was
diagnosed in accordance with standard clinical guide-
lines [12]. Patients were excluded if they had atrial fibril-
lation, significant comorbidity, or contraindications to
CMR and gadolinium-based contrast agents. The study
was approved by the National Research Ethics Service
and was conducted in accordance with the principles set
out in the declaration of Helsinki, with written informed
consent obtained from all patients.
Image acquisition
Images were acquired using a clinical 3.0 T scanner
(Magnetom Skyra, Siemens AG Healthcare Sector,
Erlangen, Germany) with an anterior 18 element matrix
coil and 8–12 elements of a matrix spine coil. The 10
patients were each scanned on two separate days (subse-
quently referred to as initial and repeat study) in order
to assess interstudy reproducibility.
After the localization steps to determine the short axis
of the left ventricle (LV), a retro-gated cine sequence
with a temporal resolution of 40 ms, acquired in a mid-
ventricular short axis plane, was used to find the timing
and duration of the subject-specific end-systolic pause.
Localized first and second-order shimming and fre-
quency adjustment were performed with an adjustment
box positioned to cover the extent of the left ventricle in
the imaged slices. cDTI was performed in the end-systolic
pause in the mid left ventricle using a diffusion-weighted
stimulated echo acquisition mode (DW-STEAM) single-
shot echo-planar imaging (EPI) sequence gated to every
other cardiac cycle [22]. Zonal-excitation was used to re-
duce the field of view in the phase encode direction and
therefore, the echo train length [26]. The following se-
quence parameters were used: b = 0 s/mm2 plus 6 diffu-
sion encoding directions, fat saturation, TR = 2 RR
intervals = 2000 ms (assuming a heart rate of 60 beats per
minute), TE = 23 ms, BW= 2442 Hz/pixel, GRAPPA
parallel imaging acceleration factor of 2, [27] field of
view = 360 × 123–157 mm2, slice thickness 8 mm, EPI
echo train length = 22–28 readouts depending on field of
view, EPI readout duration = 11–14 ms, in-plane spatial
resolution = 2.7 × 2.7 mm2 interpolated to 1.35 × 1.35 mm2,
3 slices, 4 mm slice gap. Typically 10 image repetitions were
obtained for each slice and each diffusion direction before
averaging to improve signal to noise ratio (SNR). When
motion artefacts were present due to inadequate breath
holding and ectopy, up to 13 repetitions were acquired and
Table 1 Baseline patient characteristics [mean ± SD, or
number of patients (%)]
HCM patients
(n = 10)
Age [years] 57 ± 9
Male 9 (90%)
Body Surface Area [m2] 1.99 ± 0.2
Body mass index [kg/m2] 27.5 ± 4.1
LV morphology & risk factors
Asymmetrical septal hypertrophy 7 (70%)
Apical hypertrophy 3 (30%)
Number of risk factors for sudden death: median (range) 1 (0-1)





Extent of late gadolinium enhancement: [% of LV mass] 4.5% ± 5.6%
CMR dimensions and function
Indexed LV EDV [mL/m2] 70 ± 12
Indexed LV ESV [mL/m2] 16 ± 4
LV Ejection Fraction [%] 77 ± 5
LV Mass Index [g/m2] 63 ± 12
Maximum end-diastolic Wall Thickness [mm] 22 ± 5
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rotated to avoid losing data from the same direction at the
end of each breath hold. For diffusion encoding, the ma-
ximum available on axis gradient strength of 45 mT/m was
used with a trapezoidal gradient pulse duration of 10 ms,
leading to a diffusion sensitivity of b = 350 s/mm2. Breath-
old duration was for 18 cardiac cycles, which was typically
18 s. The typical duration of the patient scan was 45
minutes.
In order to provide functional and morphological data,
breath-hold CMR was performed. Retrospectively gated
balanced steady-state free-precession cine sequences were
acquired in three long-axis planes, followed by a contigu-
ous stack of short axis slices from the atrioventricular ring
to the apex [28].
Diffusion tensor analysis
A cDTI post-processing software tool was custom-built
in house using MATLAB (Mathworks, MA, USA). It
included an interface to reject images corrupted by arte-
facts based on a visual analysis and an automatic cross-
correlation algorithm to perform a rigid co-registration of
the remaining images before averaging (translation, no ro-
tation) [29]. A rank 2 diffusion tensor was generated for
each voxel using the signal intensity data from the six
diffusion-weighted images and the reference image whereb = 0 as described in Kingsley 2006 [30]. The eigensystem
(eigenvalues and eigenvectors) was then calculated for
each tensor. Due to noise, high local anisotropy, misregis-
tration, and or artefacts, a small percentage of the mea-
sured eigenvalues are negative, violating the assumption of
a positive definite diffusion tensor. These were set to the
mean of the corresponding non-negative eigenvalues in
neighbouring voxels. Two quantitative diffusion parameter
maps were calculated from the eigensystems: Fractional
Anisotropy (FA) and Mean Diffusivity (MD) [31]. FA is an
index of the degree of deviation of the observed diffusion
from isotropic, and MD is the first moment of the diffu-
sion tensor, which is the average diffusivity.
The principal eigenvector of the diffusion tensor was
taken to represent mean intravoxel myocyte orientation.
The Helix Angle (HA) was then calculated as the angle
between the short axis plane and the projection of the
myocyte vector onto a plane tangential to the local
endocardium [32]. Left-handed epicardial helix orienta-
tions were assigned a negative angle and right handed
endocardial helix orientations a positive helix angle, as
originally described by Streeter, [33,34] with zero angle
being aligned with the local circumferential direction.
For quantitative analysis, the myocardium was divided
into 4 segments for each slice and the same segments in
each slice were grouped into the conventional LV walls
(anterior, septal, inferior, lateral) [35]. Care was taken to
exclude papillary muscle regions. HA analysis further seg-
mented the myocardium transmurally into endocardial,
mesocardial and epicardial layers. This was performed by
dividing the local myocardium into three equal thickness
layers. All cDTI analysis was performed by a single obser-
ver blinded to clinical data. 3D visualisation of the tensor
with superquadric glyphs [36] was implemented using Py-
thon and Paraview (Kitware, NM, USA) software. The
post-processing and analysis time was approximately 3
hours.
Image analysis
Ventricular volumes, function, mass, and ejection frac-
tion for all patients were measured for the LV using a
semi-automated threshold-based technique (CMRtools,
Cardiovascular Imaging Solutions, London). All volume
and mass measurements were indexed to body surface
area calculated using the Du Bois method [37,38]. Late
gadolinium enhancement (LGE) imaging was analysed to
assess fibrosis, and recorded as present/not present with
its location, and in addition the extent of LGE was quan-
tified using CMR42 software with a full-width half-max-
imum threshold and expressed as percent of LV mass.
Statistical analysis
MD and FA values were analysed globally (all segments,
all slices), by slice (3 slices), and by LV wall (common
Figure 1 Example of b0 and diffusion-encoded images (one average). This data demonstrates the typical image quality obtained
throughout the study. Multiple data sets were acquired, motion corrected and averaged before cDTI post-processing.
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analysed globally, by slice and by wall but also in 3 layers
(epicardium, mesocardium, endocardium) because of the
known transmural variation in HA. Values from the ini-
tial study were compared between LV walls, slices and
layers (for HA) using a hierarchical (patients - slices -
LV walls - layers) mixed effects model. The lateral wall
and mid slice were chosen as reference regions for com-
parison, because the lateral wall is less commonly
affected by hypertrophy in HCM, and the mid-wall is
furthest from any anomalous measurement relating to
the apex or mitral valve. All values were found to be
normally distributed using the Kolmogorov-Smirnov
test, and are therefore shown as mean ± standard de-
viation (SD). Statistical significance was set to p <0.01 to
account for the number of statistical tests performed.
Interstudy reproducibility was assessed using the SD of
the difference between the scans, and the coefficient of
variation (CoV) where reasonable (SD of the difference
between the scans divided by the measurement mean).Bland-Altman analysis was also performed. Differences
in the CoV were assessed using a variance ratio test.
Results
Study population
The baseline demographic, clinical and CMR character-
istics of the study population are summarised in Table 1.
Diffusion tensor imaging
DTI was successfully acquired in all cases. Figure 1
demonstrates a DTI dataset showing typical images be-
fore averaging. b0 images (references images without dif-
fusion weighting) after motion correction and averaging,
and derived FA, MD and HA maps at three slice loca-
tions, together with FA and MD plots for each LV myo-
cardial segment, both for the initial and repeat scans, are
shown in Figures 2 and 3. While Figure 2 displays a re-
producible data set without obvious artifacts, Figure 3
displays the least reproducible data set of this study. In
Figure 2, the MD and FA maps appear homogeneous,
Figure 2 cDTI data set for initial and repeat scan in a highly reproducible cDTI example. The three cDTI slices are depicted as b0 images
after averaging, with the derived colourised FA, MD and HA maps. The bottom images show the matching LGE slices with arrows highlighting
the enhanced regions. The plots show the measured FA and MD values for the myocardial segment regions only (the blue lines represent the
healthy mean value and the ± 2SD limits reported by Nielles-Vallespin et al., [22] and the error bars in the data points represent the standard
deviation measured in each myocardial segment). No major differences are observed between initial and repeat scans for any parameter map or
plots. The HA distribution maps look similar to the ones expected in healthy subjects and do not display obvious disarray in the area of LGE
(anterior and inferior) or elsewhere.
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Figure 3 cDTI data set for initial and repeat scan in the least reproducible example, most affected by artefacts data set of the ten
investigated in this study. The three cDTI slices are depicted as b0 images after averaging, with the derived colourised FA, MD and HA maps.
The bottom images show the matching LGE slices with arrows highlighting the enhanced regions. The plots show the measured FA and MD
values for the myocardial segment regions only (the blue lines represent the healthy mean value and the ± 2SD limits reported by
Nielles-Vallespin et al., [22] and the error bars in the data points represent the standard deviation measured in each LV wall). Differences can be
seen in FA, MD and HA maps, particularly in the mean diffusivity of the septal region mid-slice due to a signal loss artefact in the b0 images of
the repeat scan. The HA distribution maps shows noisy pixels due to motion artefacts which are not reproducible. No definite pattern of change
is seen in the area of LGE in the anterior wall or elsewhere.
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Table 2 Fractional anisotropy (FA): results from initial study
FA N Mean SD Difference 95% Confidence
interval
p value
Global 10 0.613 0.044
Slice
Mid 10 0.623 0.043 Reference
Apical 10 0.608 0.05 -0.015 -0.04 0.01 0.25
Basal 10 0.608 0.046 -0.015 -0.04 0.01 0.25
LV wall
Lateral 10 0.614 0.041 Reference
Anterior 10 0.615 0.039 0.002 -0.021 0.024 0.90
Inferior 10 0.611 0.04 -0.003 -0.026 0.019 0.79
Septal 10 0.61 0.059 -0.003 -0.026 0.019 0.77
McGill et al. Journal of Cardiovascular Magnetic Resonance 2012, 14:86 Page 7 of 15
http://www.jcmr-online.com/content/14/1/86however the transmural progression of HA can be
clearly observed and looks as expected in a healthy vol-
unteer. In Figure 3, the HA maps look perturbed.
Fractional anisotropy
The mean global FA in the 10 patients in the initial
study was 0.613 ± 0.044 (Table 2). When analysed by
slice, FA was greatest in the mid-slice (0.623 ± 0.043)
and smaller, but not significantly so in the basal and
apical slices (using the mid slice as reference). When
analysed by LV wall, FA was greatest in the anterior wall
at 0.615 ± 0.039 and least in the septal wall at 0.610 ±
0.059. Using the lateral wall as a reference, there was no
statistically significant difference between walls.
Mean diffusivity
The mean global MD was 0.750 ± 0.154 × 10-3 mm2/s
(Table 3). MD was greatest in the apical slice (0.785 ±
0.152 × 10-3 mm2/s) and least in the basal slice (0.726 ±
0.145 × 10-3 mm2/s), but there were no statisticallyTable 3 Mean diffusivity (MD): Results from initial study [×10
MD N Mean SD
Global 10 0.75 0.154
Slice
Mid 10 0.742 0.178
Apical 10 0.785 0.152
Basal 10 0.726 0.145
LV wall
Lateral 10 0.714 0.155
Anterior 10 0.758 0.145
Inferior 10 0.742 0.137
Septal 10 0.784 0.188significant differences between slices. When analysed by
LV wall, MD was significantly greater in the septal wall than
the reference lateral wall (0.784 ± 0.188 × 10-3 mm2/s vs
0.714 ± 0.155 × 10-3 mm2/s; p < 0.001).
Helix angle
Global LV helical angles (Table 4) showed transmural
progression from left handed in the epicardium (−34.3 ±
7.6°), near perpendicular to the imaging plane in the
mesocardium (3.5 ± 6.9°), to right handed in the endo-
cardium (38.9 ± 8.1°). When analysed by slice, the helical
angles were not statistically different between slices.
When analysed by LV wall, the endocardial HA was sta-
tistically more right handed in the inferior and septal
walls compared to the lateral wall (33.9 ± 8.4°, 34.1 ±
5.2° vs 42.6 ± 5.5°; both p < 0.001). In the mesocardial
layer the inferior and septal walls HA were significantly
more perpendicular to the plane than in the lateral wall
(−0.2 ± 5.7°, -0.7 ± 6.9° vs 7.6 ± 4.5°; both p < 0.001).





0.042 -0.017 0.101 0.16
-0.016 -0.075 0.043 0.60
Reference
0.044 0.004 0.083 0.029
0.028 -0.011 0.067 0.16
0.07 0.031 0.109 <0.001
Table 4 Helix angle (HA): Results from initial study [degrees]




Endo 10 38.9 8.1
Meso 10 3.5 6.9
Epi 10 −34.3 7.6
Slice
Endo layer
Mid 10 40 4.6 Reference
Apical 10 41 7.2 1 −2.6 4.7 0.58
Basal 10 36.3 6 −3.7 −7.4 −0.1 0.044
Meso layer
Mid 10 3 3.2 Reference
Apical 10 4.3 5.3 1.3 −1.5 4 0.37
Basal 10 3.5 4.3 0.5 −2.2 3.2 0.72
Epi layer
Mid 10 −34.4 3.2 Reference
Apical 10 −33.8 6.5 0.6 −3 4.2 0.73
Basal 10 −34.8 4.1 −0.4 −4 3.2 0.82
LV wall
Endo layer
Lateral 10 42.6 5.5 Reference
Anterior 10 45.1 6.6 2.5 −1.6 6.7 0.24
Inferior 10 33.9 8.4 −8.7 −12.8 −4.5 <0.001
Septal 10 34.1 5.2 −8.5 −12.6 −4.3 <0.001
Meso layer
Lateral 10 7.6 4.5 Reference
Anterior 10 7.3 6.1 −0.4 −4.6 3.9 0.87
Inferior 10 −0.2 5.7 −7.8 −12.1 −3.5 <0.001
Septal 10 −0.7 6.9 −8.3 −12.6 −4 <0.001
Epi layer
Lateral 10 −28.7 6 Reference
Anterior 10 −36.9 6.9 −8.3 −13.8 −2.7 0.004
Inferior 10 −32.4 5.4 −3.7 −9.3 1.8 0.19
Septal 10 −39.1 8.2 −10.4 −16 −4.9 <0.001
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6.9°, -39.1 ± 8.2° vs −28.7 ± 6.0° p = 0.004 & <0.001).
Reproducibility
Initial and repeat studies were performed 167 ± 21 days
apart. There were no clinical events or changes in treat-
ment in the intervening period. FA, MD and HA maps
appeared similar between initial and repeat studies in
the majority of cases (Figure 2). Figure 4 shows two pairs
of HA maps (initial vs repeat study) showing good re-
producibility (top), and an example which appears lessreproducible (bottom). Small regions with high levels of
noise (arrows) can be seen in the HA maps, thought to
be a consequence of motion, either cardiac or respira-
tory or both.
FA reproducibility data, comparing the initial and re-
peat studies are provided in Table 5 and the associated
Bland-Altman plots are shown in Figure 5. FA data ana-
lysed globally, per slice and by LV wall showed good repro-
ducibility with minimal bias and low variance. The global
SD between the initial and repeat studies was ± 0.045 and
the CoV was 7.2%.
Figure 4 Two examples of the HA maps measured in the mid slice in the initial and repeat study. Subject 1 HA maps are very similar
between the two studies, while subject 2 HA maps are not as reproducible, particularly in the septal and anterior regions. Small regions with
abnormal pixels (arrows) can often be seen in the HA maps. This is not well correlated to regions of LGE and is likely to be related to noise.
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peat studies, are provided in Table 6 and Figure 5. MD
data showed good reproducibility at each level of ana-
lysis. The global SD between the initial and repeat stud-
ies was ± 0.135 × 10-3 mm2/s and the coefficient of
variation was 18.6%. The interstudy reproducibility of
MD was significantly less good than for FA (p = 0.003).
HA reproducibility data, comparing the initial and re-
peat studies are provided in detail in Table 7. The asso-
ciated plots are shown in Figures 5 and 6. The global
mean SD for HA between the initial and repeat studiesTable 5 Fractional anisotropy (FA) reproducibility
FA N Mean value Mean
difference
Global 10 0.617 −0.008
Slice
Apical 10 0.614 −0.013
Mid 10 0.622 0.001
Basal 10 0.614 −0.013
LV wall
Anterior 10 0.620 −0.009
Lateral 10 0.608 0.012
Inferior 10 0.620 −0.018
Septal 10 0.619 −0.017was ± 4.8°, ± 3.4° and ± 2.9° in the endocardial, mesocar-
dial and epicardial layers. Analysis of HA by slice and
LV wall was similarly reproducible. Three-dimensional
analysis of the DTI data is shown in Figure 7 as super-
quadric glyphs. The colour and orientation/shape of the
glyphs are determined by the helix angle and the eigen-
system respectively.
Discussion
In-vivo cDTI is challenging due to cardiac motion and






0.045 −0.096 0.079 7.2%
0.054 −0.119 0.093 8.8%
0.051 −0.099 0.102 8.2%
0.043 −0.098 0.072 7.1%
0.042 −0.091 0.073 6.8%
0.059 −0.104 0.128 9.7%
0.053 −0.123 0.087 8.6%
0.053 −0.121 0.086 8.5%
Figure 5 Bland-Altman plots for the global FA, MD, and HA (endo-, meso-, epicardium) showing the interstudy reproducibility
between the initial and repeat studies.
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sequence at 3T can be performed in-vivo in healthy
volunteers with good reproducibility [22]. We now show
that this technique can be performed apparently suc-
cessfully in patients with HCM and have assessed itsTable 6 Mean diffusivity (MD) reproducibility (×10-3 mm2/s)
MD N Mean value Mean difference SD of d
Global 10 0.728 0.045 0
Slice
Apical 10 0.764 0.041 0
Mid 10 0.720 0.045 0
Basal 10 0.704 0.045 0
LV wall
Anterior 10 0.727 0.061 0
Lateral 10 0.713 0.003 0
Inferior 10 0.716 0.053 0
Septal 10 0.751 0.067 0interstudy reproducibility and the variation of quantita-
tive measures around the myocardium.
FA had a global value of 0.613 ± 0.044 and analysis by
slice and wall yielded similar results with no statistical
differences. The interstudy reproducibility of global FAifference 95% limits of agreement Coefficient of variation
.135 −0.220 0.310 18.6%
.176 −0.304 0.385 23.0%
.160 −0.268 0.358 22.2%
.115 −0.181 0.271 16.4%
.112 −0.158 0.281 15.4%
.164 −0.317 0.324 22.9%
.140 −0.221 0.327 19.5%
.232 −0.388 0.521 30.9%










Endo 10 38.4 1.2 4.8 −8.3 10.6
Meso 10 3.9 −0.6 3.4 −7.3 6.0
Epi 10 −33.1 −2.7 2.9 −8.4 3.0
Apical endo 10 39.5 3.0 10.6 −17.8 23.9
Apical meso 10 4.3 0.0 6.1 −12.0 12.0
Apical epi 10 −32.0 −3.6 6.4 −16.2 8.9
Mid endo 10 39.1 1.9 6.2 −10.3 14.1
Mid meso 10 3.4 −0.7 4.7 −9.9 8.4
Mid epi 10 −33.0 −2.9 6.8 −16.2 10.4
Basal endo 10 36.6 −0.8 4.4 −9.3 7.8
Basal meso 10 4.1 −1.1 3.2 −7.3 5.2
Basal epi 10 −33.9 −1.8 4.7 −11.0 7.4
LV wall
Anterior endo 10 43.2 3.7 8.6 −13.2 20.5
Anterior meso 10 6.0 2.6 5.5 −8.1 13.3
Anterior epi 10 −36.5 −0.9 7.3 −15.2 13.5
Lateral endo 10 42.6 0.0 4.9 −9.7 9.7
Lateral meso 10 8.7 −2.2 6.9 −15.8 11.4
Lateral epi 10 −27.7 −2.0 7.8 −17.4 13.3
Inferior endo 10 34.2 −0.6 6.7 −13.6 12.5
Inferior meso 10 0.7 −1.7 7.2 −15.9 12.4
Inferior epi 10 −30.8 −3.2 9.4 −21.7 15.3
Septal endo 10 33.3 1.6 8.0 −14.1 17.4
Septal meso 10 0.2 −1.8 6.8 −15.1 11.6
Septal epi 10 −36.7 −4.9 7.3 −19.3 9.5
The CoV was not calculated for HA, see text for details.
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http://www.jcmr-online.com/content/14/1/86was very good at 7.2%, with values ranging from 6.8% to
9.7% for slices and walls. This very robust reproducibility
suggests that the values have clinical validity. MD had a
global value of 0.750 ± 0.154 × 10-3 mm2/s and was signifi-
cantly higher in the septum (0.784 ± 0.188 × 10-3 mm2/s,
p < 0.001). The interstudy reproducibility of global MD
was reasonable at 18.6%, with values ranging from 15.4%
to 30.9% for slices and walls. The interstudy reproduci-
bility of MD was significantly less good than for FA
(p = 0.003).
One possible interpretation of the finding of higher
MD in the septum might be that it resulted from the
commonly found septal hypertrophy in HCM in associ-
ation with an enlarged interstitial space from disarray or
fibrosis. However, considerable caution must be observed
in the interpretation of this result because of known and
unknown technical issues. One issue might be that the
SNR across the LV is not homogeneous due to the de-
creasing sensitivity of the receiver surface coils with depth(the signal being higher the closer to the coil elements). It
is well documented in diffusion tensor imaging that FA
and MD values are biased by SNR due to the Rician noise
distribution and due to the fact that only magnitude
images are used to derive the diffusion tensor parameters
[39]. Therefore, higher SNR may lead to higher values of
MD. The evaluation of the SNR in these images is beyond
the scope of this paper, but will be the subject of future
work. Another possible confounding issue is sensitivity to
the difference in myocardial position between the 2 suc-
cessive cardiac cycles used for imaging, which might affect
different regions of the LV in a different manner and cre-
ate artefactual MD differences across the LV. A further
potential issue is mis-registration of the regions of interest
used to segment the LV, with influence of right ventricular
papillary muscles affecting the septal measurements. Fi-
nally, there will also be unidentified technical issues which
could have a bearing on the results. The relative contribu-
tion of each of these issues is currently unknown, and in-
depth analysis of larger numbers of patients and healthy
volunteers will be necessary to determine whether the
increased MD is an actual clinical finding or caused by
limitations of the present cDTI technique.
Analysis of HA was divided into 3 transmural layers
because of prior findings. The global value for endocar-
dial HA was 38.9° ± 8.1°, and SD of the difference be-
tween the measurement for the 2 scans was 4.8°. For the
mesocardium, the global value was 3.5° ± 6.9° with an
interstudy SD of 3.4°. For the epicardium, the global
value was −34.3° ± 7.6° with an interstudy SD of 2.9°.
These findings indicate very good reproducibility be-
tween scans of HA in all 3 layers and suggest clinical
validity. CoVs were not calculated because their magni-
tude is a function of the coordinate angles chosen, and
in the current system were incalculable in the mesocar-
dial layer as the mean helical angle approximates to zero
as myocyte orientation rotates from a left-handed to
right-handed helix creating unstable values by division.
Significant differences in HA were found between the
reference lateral wall and the septum in all 3 transmural
layers (ranging from 8.5° to −10.4°, all p < 0.001). Signifi-
cant differences also affected the inferior wall in the
endo and mesocardium (p < 0.001), and the anterior wall
in the epicardium (p = 0.004). One possible interpret-
ation of the finding of different HA values in the septum
is disturbance from myocardial disarray. However, once
again this interpretation needs to be regarded with con-
siderable caution. In this study the myocardium was seg-
mented transmurally into 3 equal thickness layers. This
does not necessarily represent the real left-handed, cir-
cular and right-handed HA structure of the myocardium
and therefore averaging within these 3 layers is bound to
happen. Although this should not largely affect the re-
producibility, it could influence the LV wall comparison
Figure 7 The diffusion tensor represented by superquadric glyphs in three slices (shown only in the myocardium). The glyphs represent
not only the principal diffusion direction (myocyte orientation) but also the secondary and tertiary eigenvalues along the cross-myocyte
directions.
Figure 6 Line plots of the mean global HA values in the initial and repeat study for the endo-, meso- and epicardial layers for all 10
subjects. The mean ± 1SD of each group is also shown.
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http://www.jcmr-online.com/content/14/1/86due to the varying myocardial thickness per wall seg-
ment. The segmentation might be subject-dependent
due to the fact that the papillary muscles and RV wall
are visually excluded and might differ between initial
and repeat scans, affecting the values due to mis-
registration of the region of interest, and also across
patients. The design, implementation, optimisation and
comparison of segmentation algorithms to extract robust
and meaningful quantitative HA data will be a very im-
portant task for the translation of cardiac DTI into rou-
tine, and is the subject of ongoing research. On the
other hand, HA distribution maps appeared healthy in
the majority of cases. We hypothesise that this might be
due to the fact that the patient cohort scanned for this
study was composed of stable HCM patients. There is a
possibility that this is the reason why the HA maps ap-
pear normal, and that more severe forms of HCM might
correlate with disturbed HA distribution maps.
There is relatively little previous in-vivo work on the ab-
solute values of FA and MD. In healthy human subjects
we reported an MD value of 0.8 ± 0.2 × 10-3 mm2/s using
a similar breath hold DW-STEAM protocol, [22] and
Reese et al. [40] reported an MD of 0.9 ± 0.3 × 10-3 mm2/s,
which are both within one standard deviation of the global
value of 0.750 ± 0.154 × 10-3 mm2/s found in the current
study of HCM patients. Tseng et al. performed in-vivo
DTI in 5 patients with HCM and 5 volunteers [25]. They
measured FA at 0.78 in the free wall and 0.56 in the
septum in HCM patients (p = 0.03 for the difference) and
0.78 and 0.72 respectively in normal subjects (p = 0.15 for
the difference). In our current study, we measured slightly
lower FA at 0.614 ± 0.041 × 10-3 mm2/s in the lateral wall
and 0.610 ± 0.059 × 10-3 mm2/s in the septum, with no
significant difference between our values (p = 0.77). Fur-
ther studies will be needed to compare measures, stand-
ardise and optimise the methods and further validate
results. It should be noted that the quantitative results in
this study are obtained from acquisitions at end-systole.
We might expect differences between in-vivo and ex-vivo
data, and also between fresh and fixed ex-vivo data, and
finally also between data acquired at different cardiac
phases.
The general limitations of this study are the following:
The modest in-plane resolution of 2.7 mm might lead to
volume averaging of the blood pool in endocardial layers
or the RV papillary muscles in epicardial layers, which
could bias the FA, MD and HA values in these areas;
Data acquisition was performed at end-systole, which is
considered a phase when the diffusion acquisition is not
affected by strain, [40] and although the systolic pause in
HCM is longer than in healthy volunteers, motion arti-
facts may still have occurred related to the optimal
positioning of the acquisition window; The time be-
tween the 2 scans in the study might have resulted inalteration in the myocardium due to disease progres-
sion, but this is unlikely given the slow rate of pro-
gression and the lack of any clinical events in the
intervening period; This is a preliminary study on a
small sample size of only 10 HCM patients, and fur-
ther work with a larger number of patients is required,
which will include quantitative regional comparisons
with analysis of LGE; The application of the current
technique to patients with limited breathold capability
or frequent ectopy remains to be determined, but
would be more challenging.
Conclusions
In conclusion, we have implemented a robust quantita-
tive in-vivo cDTI technique that has the potential to en-
hance our understanding of in-vivo structure-function
relationships in the HCM heart. We have shown that
cDTI of the human HCM heart in-vivo can be per-
formed using a recently reported technique, and we have
assessed the reproducibility of the results of this tech-
nique in HCM patients.
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